Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34 + Selected Grafts for Allogeneic Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34 + Selected Grafts for Allogeneic Hematopoietic Cell Transplantation

Published:2017-01 Issue:1 Volume:23 Page:67-74
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Barba Pere,Ratan Ravin,Cho Christina,Ceberio Izaskun,Hilden Patrick,Devlin Sean M.,Maloy Molly A.,Barker Juliet N.,Castro-Malaspina Hugo,Jakubowski Ann A.,Koehne Guenther,Papadopoulos Esperanza B.,Ponce Doris M.,Sauter Craig,Tamari Roni,van den Brink Marcel R.M.,Young James W.,O'Reilly Richard J.,Giralt Sergio A.,Perales Miguel-Angel

Funder

National Institutes of Health

National Institutes of Health/National Cancer Institute Cancer Center Support

Red Tematica de Investigacion Cooperativa en Cancer

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference26 articles.

1. T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease;Papadopoulos;Blood,1998

2. T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin;Jakubowski;Blood,2007

3. Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings;Castro-Malaspina;Biol Blood Marrow Transplant,2008

4. Low Risk of Chronic Graft-versus-Host Disease and Relapse Associated with T Cell–Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous Leukemia in First Remission: Results of the Blood and Marrow Transplant Clinical Trials Network Protocol 0303

5. Comparative Outcomes of Donor Graft CD34+ Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transplantation

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced Survival of Chronic Myelomonocytic Leukemia-Dysplastic over Proliferative Subtype after Allogeneic Hematopoietic Cell Transplant: A Tertiary Center Experience and Literature Review;Acta Haematologica;2024-06-26

2. Association of individual comorbidities with outcomes in allogeneic hematopoietic cell transplantation from unrelated adult donors versus unrelated cord blood: A study on behalf of the Donor/Source and Transplant Complications Working Groups of the Japanese Society for Transplantation and Cellular Therapy;American Journal of Hematology;2024-01-02

3. Evaluation and Counseling of Candidates;The EBMT Handbook;2024

4. Fifty years of BMT: risk stratification, donor matching, and stem cell collection for transplantation;Frontiers in Oncology;2023-08-28

5. In the Pipeline: Emerging Therapy for MDS and MDS/MPN;Pathogenesis and Treatment of Leukemia;2023